Marie-ange A. Reynier-Mouret
Clermont-ferrand, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications
Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort.
Journal: Breast (Edinburgh, Scotland)
Published: January 08, 2026
Return to work among self-employed breast cancer survivors from the CANTO cohort.
Journal: Scientific reports
Published: October 23, 2025
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility study.
Journal: Cancer treatment and research communications
Published: May 27, 2025
Molecular and cellular composition changes after neoadjuvant letrozole and palbociclib in early luminal breast cancer.
Journal: Cell reports. Medicine
Published: February 20, 2025
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
Journal: Cancer epidemiology
Published: November 20, 2024
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
Journal: The New England journal of medicine
Published: September 16, 2024
Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: July 15, 2024
Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe).
Journal: JNCI cancer spectrum
Published: July 14, 2024
18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study.
Journal: Breast cancer research : BCR
Published: May 03, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 17, 2024
Last Updated: 09/26/2026